The number of new diabetes patients amongst the U.S. adults keeps declining, even as obesity rates surge and health executives are not clear why. New federal statistics were released recently and found that the number of new diabetes cases reduced to almost 1.3 Million in 2017, which is down from 1.7 Million in 2009. The past research had identified a decline and the latest report shows it has been going on for a decade. Dr. Stephen Benoit—from the CDC (Centers for Disease Control and Prevention)—said, “The bottom line is we are not aware what is driving these trends.” Amongst the possibilities, modifications in testing and getting people to enhance their health prior to becoming diabetic. The report was issued in BMJ Open Diabetes Research & Care.
Reportedly, diabetes is a disorder in which sugar is build up in the blood. The most ordinary form is associated with obesity, and the number of diabetics patients increased as the obesity rates increased. But other aspects also may have pushed up yearly diabetes diagnoses from 2000–2010, and they might partly clarify why the numbers have been declaring since some experts said. Seemingly, the diagnostic threshold was reduced in the late 1990s. That leads to more people to be counted as diabetic patients, but the effect of that might have played out.
On a similar note, recently, a study showed that T2DM (type II diabetes mellitus) is a peril factor for liver fibrosis progression in NAFLD (nonalcoholic fatty liver disease). The study was published in the Journal of Gastroenterology and Hepatology. Toshifumi Tada—from Ogaki Municipal Hospital, Japan—along with colleagues analyzed clinical jeopardy factors for advancement of liver fibrosis in patients having NAFLD. The information was included for 1,562 patients having NAFLD (aged from 36 Years to 64 Years) and less severe liver fibrosis.